DESTIN, Fla. — New treatments have improved outcomes in lupus, but preventing disease in the early stages remains elusive, according to a speaker at the Congress of Clinical Rheumatology East.“We have seen amazing progress in lupus,” Judith A. James, MD, PhD, executive vice president and chief medical officer of the arthritis and clinical immunology research program at Oklahoma